USPTO serial 86880807
THIOPLEX
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEIPZIG, MARC J
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with THIOPLEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sherry Flax
SHERRY FLAX SAUL EWING LLP500 E. PRATT ST.SUITE 900BALTIMORE, MD 21202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer | ACTIVE | — |
| 005 | Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical agents affecting metabolism; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer; Anti-cancer preparations; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Hexim Pharmaceuticals Inc.
- Other trademarks owned by Hexim Pharmaceuticals Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named THIOPLEX
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 12, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 12, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 9, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 7, 2017 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 7, 2017 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 7, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 24, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 23, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 19, 2017 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 27, 2017 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Apr 27, 2017 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Apr 27, 2017 | PETG | PETITION TO REVIVE-GRANTED | — |
| Apr 27, 2017 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Mar 13, 2017 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 13, 2017 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 9, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 9, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 14, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 14, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 25, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 5, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 5, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 5, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 5, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 5, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 5, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 25, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 23, 2016 | NWAP | NEW APPLICATION ENTERED | — |